Phosphorylation of RyR2 and shortening of RyR2 cluster spacing in spontaneously hypertensive rat with heart failure

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 293, Issue 4, 2007, Pages

  Chen Izu, Ye ^a   Ward, Christopher W ^b   Stark Jr , Wayne ^c   Banyasz, Tamas ^a,d   Sumandea, Marius P ^a   Balke, C William ^a   Izu, Leighton T ^a   Wehrens, Xander H T ^e  

^a UNIVERSITY OF KENTUCKY   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF NURSING   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF DEBRECEN   (Hungary)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac hypertrophy; Hypertension; Protein kinase A; Ryanodine receptor; Spontaneously hypertensive rat

Indexed keywords

CALCIUM; RYANODINE RECEPTOR 2; SERINE; CYCLIC AMP DEPENDENT PROTEIN KINASE; RYANODINE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; HEART ARRHYTHMIA; HEART FAILURE; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; RAT; SIMULATION; SPONTANEOUSLY HYPERTENSIVE HEART FAILURE RAT; WESTERN BLOTTING; ANIMAL; BIOLOGICAL MODEL; CARDIOMEGALY; COMPUTER SIMULATION; DISEASE COURSE; DISEASE MODEL; ENZYMOLOGY; HEART MUSCLE; METABOLISM; METHODOLOGY; PATHOLOGY; PHOSPHORYLATION; REPRODUCIBILITY; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

ANIMALS; BLOTTING, WESTERN; CALCIUM; CARDIOMEGALY; COMPUTER SIMULATION; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HEART FAILURE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; MALE; MODELS, CARDIOVASCULAR; MYOCARDIUM; PHOSPHORYLATION; RATS; RATS, INBRED SHR; RATS, INBRED WKY; REPRODUCIBILITY OF RESULTS; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SERINE;

EID: 35348971380     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00562.2007     Document Type: Article

References (49)

1. 2+ leak in heart failure. Circ Res 97: 1314-1322, 2005.
2. Bers DM. Macromolecular complexes regulating cardiac ryanodine receptor function. J Mol Cell Cardiol 37: 417-429, 2004.
3. 2+ transport. Circ Res 93: 487-490, 2003.
4. Bing OH, Brooks WW, Robinson KG, Slawsky MT, Hayes JA, Litwin SE, Sen S, Conrad CH. The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure. J Mol Cell Cardiol 27: 383-396, 1995.
5. 2+ be antiarrhythmic? Pharmacol Ther 108: 149-179, 2005.
6. Brooks WW, Bing OH, Litwin SE, Conrad CH, Morgan JP. Effects of treppe and calcium on intracellular calcium and function in the failing heart from the spontaneously hypertensive rat. Hypertension 24: 347-356, 1994.
7. Chen-Izu Y, McCulle SL, Ward CW, Soeller C, Allen BM, Rabang C, Cannell MB, Balke CW, Izu LT. Three-dimensional distribution of ryanodine receptor clusters in cardiac myocytes. Biophys J 91: 1-13, 2006.
8. Conrad CH, Brooks WW, Robinson KG, Bing OH. Impaired myocardial function in spontaneously hypertensive rats with heart failure. Am J Physiol Heart Circ Physiol 260: H136-H145, 1991.
9. Drazner MH. The transition from hypertrophy to failure: how certain are we? Circulation 112: 936-938, 2005.
10. Evans SJ, Levi AJ, Jones JV. Wall stress induced arrhythmia is enhanced by low potassium and early left ventricular hypertrophy in the working rat heart. Cardiovasc Res 29: 555-562, 1995.
11. Frohlich ED. Current issues in hypertension. Old questions with new answers and new questions. Med Clin North Am 76: 1043-1056, 1992.
12. Gomez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ. Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276: 800-806, 1997.
13. 2+/calmodulin- dependent protein kinase II phosphorylation of ryanodine receptor does affect calcium sparks in mouse ventricular myocytes. Circ Res 99: 398-406, 2006.
14. Izu LT, Means SA, Shadid JN, Chen-Izu Y, Balke CW. Interplay of ryanodine receptor distribution and calcium dynamics. Biophys J 91: 95-112, 2006.
15. 2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 91: 1015-1022, 2002.
16. Kennelly PJ, Krebs EG. Consensus sequences as substrate specificity determinants for protein kinases and protein phosphatases. J Biol Chem 266: 15555-15558, 1991.
17. Kohlhaas M, Zhang T, Seidler T, Zibrova D, Dybkova N, Steen A, Wagner S, Chen L, Heller Brown J, Bers DM, Maier LS. Increased sarcoplasmic reticulum calcium leak but unaltered contractility by acute CaMKII overexpression in isolated rabbit cardiac myocytes. Circ Res 98: 235-244, 2006.
18. Lehnart SE, Wehrens XH, Reiken S, Warrier S, Belevych AE, Harvey RD, Richter W, Jin SL, Conti M, Marks AR. Phosphodiesterase 4D deficiency in the ryanodine-receptor complex promotes heart failure and arrhythmias. Cell 123: 25-35, 2005.
19. Li Y, Kranias EG, Mignery GA, Bers DM. Protein kinase A phosphorylation of the ryanodine receptor does not affect calcium sparks in mouse ventricular myocytes. Circ Res 90: 309-316, 2002.
20. Kaminsky M, Dike U, Afari-Armah N, Chen-Izu Y, Solaro RJ, Sumandea MP. Differential phosphorylation of cTnT, cTnI and MLC2 with heart disease progression from pre-hypertension to heart failure. 2005 Biophysical Society Meeting Abstracts. Biophysical Journal, Suppl, 1542-Poster, 2005.
21. 2+ release. Circ Res 92: 904-911, 2003.
22. Marks AR, Marx SO, Reiken S. Regulation of ryanodine receptors via macromolecular complexes: a novel role for leucine/isoleucine zippers. Trends Cardiovasc Med 12: 166-170, 2002.
23. Marks AR, Reiken S, Marx SO. Progression of heart failure: is protein kinase A hyperphosphorylation of the ryanodine receptor a contributing factor? Circulation 105: 272-275, 2002.
24. Marx SO, Reiken S, Hisamatsu Y, Jayaraman T, Burkhoff D, Rosemblit N, Marks AR. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 101: 365-376, 2000.
25. Matkowskyj KA, Cox R, Jensen RT, Benya RV. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J Histochem Cytochem 51: 205-214, 2003.
26. Obayashi M, Xiao B, Stuyvers BD, Davidoff AW, Mei J, Chen SRW, ter Keurs HEDJ. Spontaneous diastolic contractions and phosphorylation of the cardiac ryanodine receptor at serine-2808 in congestive heart failure in rat. Cardiovasc Res 69: 140-151, 2006.
27. Pahor M, Bernabei R, Sgadari A, Gambassi G Jr, Lo Giudice P, Pacifici L, Ramacci MT, Lagrasta C, Olivetti G, Carbonin P. Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 18: 148-157, 1991.
28. Pahor MLGP, Bernabei R, Di Gennaro M, Pacifici L, Ramacci MT, Carbonin PU. Age-related increase in the incidence of ventricular arrhythmias in isolated hearts from spontaneously hypertensive rats. Cardiovasc Drugs Ther 3: 163-169, 1989.
29. Pyle WG, Sumandea MP, Solaro RJ, de Tombe PP. Troponin I serines 43/45 and regulation of cardiac myofilament function. Am J Physiol Heart Circ Physiol 283: H1215-H1224, 2002.
30. Reiken S, Gaburjakova M, Gaburjakova J, He KL, Prieto A, Becker E, Yi GH, Wang J, Burkhoff D, Marks AR. β-Adrenergic receptor blockers restore cardiac calcium release channel (ryanodine receptor) structure and function in heart failure. Circulation 104: 2843-2848, 2001.
31. Reiken S, Gaburjakova M, Guatimosim S, Gomez AM, D'Armiento J, Burkhoff D, Wang J, Vassort G, Lederer WJ, Marks AR. Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. J Biol Chem 278: 444-453, 2003.
32. Reiken S, Wehrens XH, Vest JA, Barbone A, Klotz S, Mancini D, Burkhoff D, Marks AR. β-Blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure. Circulation 107: 2459-2466, 2003.
33. Rodriguez P, Bhogal MS, Colyer J. Stoichiometric phosphorylation of cardiac ryanodine receptor on serine 2809 by calmodulin-dependent kinase II and protein kinase A. J Biol Chem 278: 38593-38600, 2003.
34. Rysa J, Leskinen H, Ilves M, Ruskoaho H. Distinct upregulation of extracellular matrix genes in transition from hypertrophy to hypertensive heart failure. Hypertension 45: 927-933, 2005.
35. Slama M, Ahn J, Varagic J, Susic D, Frohlich ED. Long-term left ventricular echocardiographic follow-up of SHR and WKY rats: effects of hypertension and age. Am J Physiol Heart Circ Physiol 286: H181-H185, 2004.
36. 2+ efflux theory and practice. Prog Biophys Mol Biol 90: 172-185, 2006.
37. Song LS, Sobie EA, McCulle S, Lederer WJ, Balke CW, Cheng H. Orphaned ryanodine receptors in the failing heart. Proc Natl Acad Sci USA 103: 4305-4310, 2006.
38. Sumandea MP, Pyle WG, Kobayashi T, de Tombe PP, Solaro RJ. Identification of a functionally critical protein kinase C phosphorylation residue of cardiac troponin T. J Biol Chem 278: 35135-35144, 2003.
39. 2+-sensitivity of the contractile apparatus in end-stage human heart failure results from altered phosphorylation of contractile proteins. Cardiovasc Res 57: 37-47, 2003.
40. Venetucci L, Trafford AW, Eisner DA. Illuminating sarcoplasmic reticulum calcium. Circ Res 93: 4-5, 2003.
41. 2+] in left ventricular trabeculae from failing rat hearts. J Physiol 546: 537-550, 2003.
42. Wehrens XH, Lehnart SE, Huang F, Vest JA, Reiken SR, Mohler PJ, Sun J, Guatimosim S, Song LS, Rosemblit N, D'Armiento JM, Napolitano C, Memmi M, Priori SG, Lederer WJ, Marks AR. FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death. Cell 113: 829-840, 2003.
43. Wehrens XH, Lehnart SE, Marks AR. Intracellular calcium release and cardiac disease. Annu Rev Physiol 67: 69-98, 2005.
44. Wehrens XH, Lehnart SE, Reiken S, van der Nagel R, Morales R, Sun J, Cheng Z, Deng SX, de Windt LJ, Landry DW, Marks AR. Enhancing calstabin binding to ryanodine receptors improves cardiac and skeletal muscle function in heart failure. Proc Natl Acad Sci USA 102: 9607-9612, 2005.
45. Wehrens XH, Lehnart SE, Reiken S, Vest JA, Wronska A, Marks AR. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci USA 103: 511-518, 2006.
46. 2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor. Circ Res 94: e61-e70, 2004.
47. Witcher DR, Kovacs RJ, Schulman H, Cefali DC, Jones LR. Unique phosphorylation site on the cardiac ryanodine receptor regulates calcium channel activity. J Biol Chem 266: 11144-11152, 1991.
48. Xiao B, Zhong G, Obayashi M, Yang D, Chen K, Walsh MP, Shimoni Y, Cheng H, Ter Keurs H, Chen SR. Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon β-adrenergic stimulation in normal and failing hearts. Biochem J 396: 7-16, 2006.
49. Yano M, Kobayashi S, Kohno M, Doi M, Tokuhisa T, Okuda S, Suetsugu M, Hisaoka T, Obayashi M, Ohkusa T, Kohno M, Matsuzaki M. FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. Circulation 107: 477-484, 2003.